56 results
SC TO-T
EX-99
PNT
POINT Biopharma Global Inc.
13 Oct 23
Third party tender offer statement
6:52am
-intrusion, terrorism, or any escalation or worsening of any of the foregoing;
(E) any epidemic, pandemic (including COVID-19), disease outbreak or other
SC14D9C
EX-2.1
PNT
POINT Biopharma Global Inc.
3 Oct 23
Written communication relating to third party tender offer
7:37am
or terrorism, or any escalation or worsening of any of the foregoing, (E) any epidemic, pandemic (including COVID-19), disease outbreak or other public
8-K
EX-2.1
PNT
POINT Biopharma Global Inc.
3 Oct 23
Tender and Support Agreement
7:35am
or terrorism, or any escalation or worsening of any of the foregoing, (E) any epidemic, pandemic (including COVID-19), disease outbreak or other public
ARS
m3y tegzrmk
1 May 23
Annual report to shareholders
1:52pm
424B5
nax3l25w9p8j
14 Sep 22
Prospectus supplement for primary offering
4:12pm
424B5
a3cwdqwapdab9
13 Sep 22
Prospectus supplement for primary offering
5:19pm
424B3
71g59
11 Jul 22
Prospectus supplement
4:32pm
POS AM
3ih7g j6z
1 Jul 22
Prospectus update (post-effective amendment)
4:17pm
S-3
35nkxotdqi66ztovwy
1 Jul 22
Shelf registration
4:13pm
424B3
ekufl9l7nvyd 01ic6
13 May 22
Prospectus supplement
8:18am
424B3
6lw rxk1y
31 Mar 22
Prospectus supplement
11:42am